News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alkermes plc (ALKS) Files Trademark Infringement Suit Against Boston-Based Biotech Startup Alkeus Pharmaceuticals


6/6/2014 6:57:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Irish drug giant Alkermes has filed a trademark infringement lawsuit against a four-year old Boston biotech with a very similar name. Alkermes, a 1,200-employee, 25-year-old company with a research facility in Waltham that makes drugs for diseases of the central nervous system, filed the suit on May 27 against Alkeus Pharmaceuticals. Alkeus touts Josh Boger, founder of Vertex Pharmaceuticals, as its executive chairman. The suit, filed in the U.S. District Court in Massachusetts, claims that the Boston biotech’s name would be easily mistaken for the Irish one’s, especially considering they are both involved in clinical drug development in the Boston area.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES